HCA Healthcare, Inc. $HCA Shares Sold by Sound View Wealth Advisors Group LLC

Sound View Wealth Advisors Group LLC cut its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 23.3% in the 2nd quarter, Holdings Channel reports. The fund owned 5,647 shares of the company’s stock after selling 1,714 shares during the quarter. Sound View Wealth Advisors Group LLC’s holdings in HCA Healthcare were worth $2,163,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors have also modified their holdings of HCA. Brighton Jones LLC purchased a new position in HCA Healthcare in the 4th quarter valued at $1,021,000. Crossmark Global Holdings Inc. boosted its holdings in shares of HCA Healthcare by 1.8% in the first quarter. Crossmark Global Holdings Inc. now owns 2,445 shares of the company’s stock valued at $845,000 after acquiring an additional 44 shares in the last quarter. Brown Advisory Inc. raised its holdings in HCA Healthcare by 53.9% during the first quarter. Brown Advisory Inc. now owns 4,630 shares of the company’s stock worth $1,600,000 after purchasing an additional 1,622 shares in the last quarter. Rehmann Capital Advisory Group boosted its holdings in HCA Healthcare by 7.1% in the 1st quarter. Rehmann Capital Advisory Group now owns 971 shares of the company’s stock valued at $336,000 after purchasing an additional 64 shares in the last quarter. Finally, Allworth Financial LP lifted its holdings in shares of HCA Healthcare by 8.7% in the 1st quarter. Allworth Financial LP now owns 798 shares of the company’s stock valued at $272,000 after buying an additional 64 shares during the period. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Stock Performance

HCA stock opened at $476.33 on Friday. The stock’s 50 day moving average price is $427.73 and its 200 day moving average price is $391.81. The firm has a market cap of $108.70 billion, a P/E ratio of 18.41, a PEG ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 1 year low of $289.98 and a 1 year high of $478.88.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, October 24th. The company reported $6.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The business had revenue of $19.16 billion for the quarter, compared to the consensus estimate of $18.55 billion. During the same period in the prior year, the business earned $4.90 earnings per share. The business’s revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, research analysts predict that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date of this dividend is Monday, December 15th. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Buying and Selling

In related news, EVP Michael S. Cuffe sold 3,836 shares of the company’s stock in a transaction on Monday, September 8th. The stock was sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president owned 3,487 shares of the company’s stock, valued at $1,652,105.73. This trade represents a 52.74% decrease in their position. The SEC filing for this sale provides additional information. 1.30% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts have issued reports on HCA shares. Morgan Stanley set a $425.00 price objective on HCA Healthcare in a research report on Monday, October 27th. Cantor Fitzgerald reiterated an “overweight” rating on shares of HCA Healthcare in a research note on Monday, October 27th. The Goldman Sachs Group increased their target price on shares of HCA Healthcare from $470.00 to $520.00 and gave the company a “buy” rating in a report on Monday, October 27th. Wells Fargo & Company upped their price target on HCA Healthcare from $375.00 to $412.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 7th. Finally, Truist Financial lifted their price objective on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a report on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $473.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.